STOCK TITAN

Capstone Holding Corp. Announces Change in Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
Capstone Holding Corp. (OTCQB:CAPS) accepted the resignations of Frederic R. Feldman, PhD, and Elwood D. Howse, Jr. from its board of directors. John M. Holliman, III, will assume the lead independent director role and serve as Chairman of the Company's Audit Committee.
Positive
  • None.
Negative
  • None.

ALSIP, IL / ACCESSWIRE / December 29, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company")

Effective December 28, 2023, the Company accepted the resignations of Frederic R. Feldman, PhD, and Elwood D. Howse, Jr. from its board of directors. The Company thanks Mssrs. Feldman and Howse for their many years of dedicated and valuable service.

John M. Holliman, III, will assume the lead independent director role and will serve as Chairman of the Company's Audit Committee effective as of this date.

Please see the Company's Annual Report filed with the OTCQB Markets for further information.

About Capstone Holding Corp.

The Company's primary business activities presently include the operations of TotalStone, LLC, a construction materials company.

Capstone's corporate headquarters is located in Alsip, Illinois. For more information, please visit the Company's website: www.capstonethx.com.

Statements in this press release or otherwise attributable to Capstone regarding our business that are not historical facts are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted results. These risks include the factors discussed in our Annual Report for the fiscal year ended December 31, 2022, and other documents we filed with the U.S. Securities and Exchange Commission or OTCQB Markets.

FOR FURTHER INFORMATION:

Investor Relations
(708)371-0660
investorinquiries@capstonethx.com

SOURCE: Capstone Therapeutics Corp.



View the original press release on accesswire.com

FAQ

Who resigned from Capstone Holding Corp. (OTCQB:CAPS) board of directors?

Frederic R. Feldman, PhD, and Elwood D. Howse, Jr. resigned from the board of directors.

Who will assume the lead independent director role at Capstone Holding Corp. (OTCQB:CAPS)?

John M. Holliman, III, will assume the lead independent director role.

What role will John M. Holliman, III, serve at Capstone Holding Corp. (OTCQB:CAPS)?

John M. Holliman, III, will also serve as Chairman of the Company's Audit Committee.

Where can further information be found about Capstone Holding Corp. (OTCQB:CAPS)?

Please see the Company's Annual Report filed with the OTCQB Markets for further information.

Capstone Holding Corp.

OTC:CAPS

CAPS Rankings

CAPS Latest News

CAPS Stock Data

819.57k
1.13%
0.07%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
Tempe

About CAPS

capstone therapeutics (otcqb: caps) is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. capstone holds an fda orphan drug designation for its lead molecule, aem-28, for homozygous familial hypercholesterolemia (hofh) and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.